Raising the Bar for Therapeutic Trials in Advanced Prostate Cancer

被引：2

作者：

Alumkal, Joshi J. ^{[1
]}

Beer, Tomasz M. ^{[1
]}

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 25期

关键词：

DOCETAXEL PLUS PREDNISONE; PHASE-III TRIAL; DOUBLE-BLIND; CLINICAL-TRIALS; PLACEBO; MEN; CABOZANTINIB; MITOXANTRONE; COMBINATION;

D O I：

10.1200/JCO.2016.68.0439

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：2958 / +

页数：5

共 25 条

[1] Why Do Phase III Clinical Trials in Oncology Fail so Often? [J].

Amiri-Kordestani, Laleh ;

Fojo, Tito .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (08) :568-569

[2]

[Anonymous], P GEN CANC S

[3] Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer [J].

Antonarakis, Emmanuel S. ;

Lu, Changxue ;

Luber, Brandon ;

Wang, Hao ;

Chen, Yan ;

Nakazawa, Mary ;

Nadal, Rosa ;

Paller, Channing J. ;

Denmeade, Samuel R. ;

Carducci, Michael A. ;

Eisenberger, Mario A. ;

Luo, Jun .

JAMA ONCOLOGY, 2015, 1 (05) :582-591

[4] AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer [J].

Antonarakis, Emmanuel S. ;

Lu, Changxue ;

Wang, Hao ;

Luber, Brandon ;

Nakazawa, Mary ;

Roeser, Jeffrey C. ;

Chen, Yan ;

Mohammad, Tabrez A. ;

Chen, Yidong ;

Fedor, Helen L. ;

Lotan, Tamara L. ;

Zheng, Qizhi ;

De Marzo, Angelo M. ;

Isaacs, John T. ;

Isaacs, William B. ;

Nadal, Rosa ;

Paller, Channing J. ;

Denmeade, Samuel R. ;

Carducci, Michael A. ;

Eisenberger, Mario A. ;

Luo, Jun .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) :1028-1038

[5] Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial [J].

Araujo, John C. ;

Trudel, Geralyn C. ;

Saad, Fred ;

Armstrong, Andrew J. ;

Yu, Evan Y. ;

Bellmunt, Joaquim ;

Wilding, George ;

McCaffrey, John ;

Serrano, Sergio V. ;

Matveev, Vsevolod B. ;

Efstathiou, Eleni ;

Oudard, Stephane ;

Morris, Michael J. ;

Sizer, Bruce ;

Goebell, Peter J. ;

Heidenreich, Axel ;

de Bono, Johann S. ;

Begbie, Stephen ;

Hong, Jun H. ;

Richardet, Eduardo ;

Gallardo, Enrique ;

Paliwal, Prashni ;

Durham, Susan ;

Cheng, Shinta ;

Logothetis, Christopher J. .

LANCET ONCOLOGY, 2013, 14 (13) :1307-1316

[6]

Chi KN, 2015, J CLIN ONCOL S, V33

[7] Castration-Resistant Prostate Cancer: AUA Guideline Amendment [J].

Cookson, Michael S. ;

Lowrance, William T. ;

Murad, Mohammad H. ;

Kibel, Adam S. .

JOURNAL OF UROLOGY, 2015, 193 (02) :491-499

[8] American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes [J].

Ellis, Lee M. ;

Bernstein, David S. ;

Voest, Emile E. ;

Berlin, Jordan D. ;

Sargent, Daniel ;

Cortazar, Patricia ;

Garrett-Mayer, Elizabeth ;

Herbst, Roy S. ;

Lilenbaum, Rogerio C. ;

Sima, Camelia ;

Venook, Alan P. ;

Gonen, Mithat ;

Schilsky, Richard L. ;

Meropol, Neal J. ;

Schnipper, Lowell E. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (12) :1277-+

[9] Phase III, Randomized, Placebo-Controlled Study of Docetaxel in Combination With Zibotentan in Patients With Metastatic Castration-Resistant Prostate Cancer [J].

Fizazi, Karim S. ;

Higano, Celestia S. ;

Nelson, Joel B. ;

Gleave, Martin ;

Miller, Kurt ;

Morris, Thomas ;

Nathan, Faith E. ;

McIntosh, Stuart ;

Pemberton, Kristine ;

Moul, Judd W. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (14) :1740-+

[10] Assumptions of Expected Benefits in Randomized Phase III Trials Evaluating Systemic Treatments for Cancer [J].

Gan, Hui K. ;

You, Benoit ;

Pond, Gregory R. ;

Chen, Eric X. .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (08) :590-598

← 1 2 3 →